150 related articles for article (PubMed ID: 3815380)
1. Growth inhibition by progestins in a human endometrial cancer cell line with estrogen-independent progesterone receptors.
Terakawa N; Hayashida M; Shimizu I; Ikegami H; Wakimoto H; Aono T; Tanizawa O; Matsumoto K; Nishida M
Cancer Res; 1987 Apr; 47(7):1918-23. PubMed ID: 3815380
[TBL] [Abstract][Full Text] [Related]
2. [Growth inhibition by progestins in human endometrial cancer cells with progesterone receptors].
Tanizawa O; Terakawa N
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):917-23. PubMed ID: 3389835
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.
Horwitz KB; Freidenberg GR
Cancer Res; 1985 Jan; 45(1):167-73. PubMed ID: 3838085
[TBL] [Abstract][Full Text] [Related]
4. RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins.
Terakawa N; Shimizu I; Tanizawa O; Matsumoto K
J Steroid Biochem; 1988 Aug; 31(2):161-6. PubMed ID: 2457133
[TBL] [Abstract][Full Text] [Related]
5. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
6. Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA.
Lin VC; Ng EH; Aw SE; Tan MG; Ng EH; Chan VS; Ho GH
Clin Cancer Res; 1999 Feb; 5(2):395-403. PubMed ID: 10037189
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-insensitive progesterone receptors in a human breast cancer cell line: characterization of receptors and of a ligand exchange assay.
Mockus MB; Lessey BA; Bower MA; Horwitz KB
Endocrinology; 1982 May; 110(5):1564-71. PubMed ID: 7200421
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and responsiveness to estrogen of human endometrial cancer cells under serum-free culture conditions.
Holinka CF; Anzai Y; Hata H; Kimmel N; Kuramoto H; Gurpide E
Cancer Res; 1989 Jun; 49(12):3297-301. PubMed ID: 2720684
[TBL] [Abstract][Full Text] [Related]
9. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
Pihie AH; Stanslas J; Din LB
Anticancer Res; 1998; 18(3A):1739-43. PubMed ID: 9673398
[TBL] [Abstract][Full Text] [Related]
10. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
12. Photoaffinity labeling of the progesterone receptor from human endometrial carcinoma.
Clarke CL; Satyaswaroop PG
Cancer Res; 1985 Nov; 45(11 Pt 1):5417-20. PubMed ID: 4053015
[TBL] [Abstract][Full Text] [Related]
13. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-sensitive progestin binding sites in the brain of the lizard, Anolis carolinensis.
Tokarz RR; Crews D; McEwen BS
Brain Res; 1981 Sep; 220(1):95-105. PubMed ID: 7196792
[TBL] [Abstract][Full Text] [Related]
15. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture.
Vignon F; Bardon S; Chalbos D; Rochefort H
J Clin Endocrinol Metab; 1983 Jun; 56(6):1124-30. PubMed ID: 6682424
[TBL] [Abstract][Full Text] [Related]
17. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
[TBL] [Abstract][Full Text] [Related]
18. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.
Smid-Koopman E; Blok LJ; Kühne LC; Burger CW; Helmerhorst TJ; Brinkmann AO; Huikeshoven FJ
J Soc Gynecol Investig; 2003 Jan; 10(1):49-57. PubMed ID: 12517594
[TBL] [Abstract][Full Text] [Related]
19. Effects of 17 beta-estradiol on progesterone receptors and the uptake of thymidine in human breast cancer cell line CAMA-1.
Yu WC; Leung BS; Gao YL
Cancer Res; 1981 Dec; 41(12 Pt 1):5004-9. PubMed ID: 7307001
[TBL] [Abstract][Full Text] [Related]
20. Functional estrogen receptor beta in colon cancer cells.
Fiorelli G; Picariello L; Martineti V; Tonelli F; Brandi ML
Biochem Biophys Res Commun; 1999 Aug; 261(2):521-7. PubMed ID: 10425218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
